PSA-NCAM constitutes definitively a powerful functional β-cell marker which may provide further insight in β-cell plasticity and lead to the identification of new targets in order to improve the functional status of β-cells with low secretory capacities such as in advanced type 2 diabetes. The gene discussed is NCAM1; the disease is type 2 diabetes mellitus.